Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8685)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2015 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Del Campo JA, Romero-Gómez M. Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies. World J Gastroenterol 2015; 21(38): 10776-10782 [PMID: 26478669 DOI: 10.3748/wjg.v21.i38.10776] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i38/10776.htm |
| Number | Citing Articles |
| 1 |
Tamara Revuelto Artigas, Àngels Betriu Bars, Natividad Zaragoza Velasco, Xavier Gómez Arbones, Teresa Vidal Ballester, Carme Piñol Felis, Josep Maria Reñé Espinet. Antiviral treatment does not improve subclinical atheromatosis in patients with chronic hepatitis caused by hepatitis C virus. Gastroenterología y Hepatología (English Edition) 2019; 42(6): 362 doi: 10.1016/j.gastre.2019.02.031
|
| 2 |
Jun Dai, Huan Wang, Ying Liao, Lei Tan, Yingjie Sun, Cuiping Song, Weiwei Liu, Chan Ding, Tingrong Luo, Xusheng Qiu. Non-Targeted Metabolomic Analysis of Chicken Kidneys in Response to Coronavirus IBV Infection Under Stress Induced by Dexamethasone. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.945865
|
| 3 |
Zhi-qin Li, Xin-yu Gu, Jin-xing Hu, Yu Ping, Hua Li, Jing-ya Yan, Juan Li, Ran Sun, Zu-jing Yu, Yi Zhang. Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling. Bioscience Reports 2016; 36(3) doi: 10.1042/BSR20160088
|
| 4 |
Mark R Pedersen, Amit Patel, David Backstedt, Myunghan Choi, Anil B Seetharam. Genotype specific peripheral lipid profile changes with hepatitis C therapy. World Journal of Gastroenterology 2016; 22(46): 10226-10231 doi: 10.3748/wjg.v22.i46.10226
|
| 5 |
Andrew Lever, Ulrich Desselberger. Rotavirus replication and the role of cellular lipid droplets: New therapeutic targets?. Journal of the Formosan Medical Association 2016; 115(6): 389 doi: 10.1016/j.jfma.2016.02.004
|
| 6 |
Rosanna Villani, Francesca Di Cosimo, Antonino Davide Romano, Moris Sangineto, Gaetano Serviddio. Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93251-3
|
| 7 |
Christina Sølund, Philip Hasbak, Andreas Knudsen, Andreas Kjaer, Anne M. Lebech, Nina Weis. Myocardial perfusion reserve in patients with chronic hepatitis C before and after direct‐acting antiviral treatment—a pilot study. Clinical Physiology and Functional Imaging 2022; 42(6): 389 doi: 10.1111/cpf.12772
|
| 8 |
Imesha W. De Silva, Subhayu Nayek, Vijay Singh, Jay Reddy, John K. Granger, Guido F. Verbeck. Paper spray mass spectrometry utilizing Teslin® substrate for rapid detection of lipid metabolite changes during COVID-19 infection. The Analyst 2020; 145(17): 5725 doi: 10.1039/D0AN01074J
|
| 9 |
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosis. Revista Clínica Española (English Edition) 2019; 219(6): 293 doi: 10.1016/j.rceng.2019.02.008
|
| 10 |
Keke Wu, Shuangqi Fan, Linke Zou, Feifan Zhao, Shengming Ma, Jindai Fan, Xiaowen Li, Mingqiu Zhao, Huichao Yan, Jinding Chen. Molecular Events Occurring in Lipophagy and Its Regulation in Flaviviridae Infection. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.651952
|
| 11 |
Marwa Zahra, Hassan Azzazy, Ahmed Moustafa. Transcriptional Regulatory Networks in Hepatitis C Virus-induced Hepatocellular Carcinoma. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32464-5
|
| 12 |
Tamara Revuelto Artigas, Àngels Betriu Bars, Natividad Zaragoza Velasco, Xavier Gómez Arbones, Teresa Vidal Ballester, Carme Piñol Felis, Josep Maria Reñé Espinet. El tratamiento antiviral no mejora la ateromatosis subclínica en pacientes con hepatitis crónica por virus de la hepatitis C. Gastroenterología y Hepatología 2019; 42(6): 362 doi: 10.1016/j.gastrohep.2019.02.002
|
| 13 |
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínica. Revista Clínica Española 2019; 219(6): 293 doi: 10.1016/j.rce.2018.12.007
|
| 14 |
Jun Dai, Huan Wang, Ying Liao, Lei Tan, Yingjie Sun, Cuiping Song, Weiwei Liu, Xusheng Qiu, Chan Ding. Coronavirus Infection and Cholesterol Metabolism. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.791267
|
| 15 |
Alexia Karen Cotte, Vanessa Cottet, Virginie Aires, Thomas Mouillot, Maud Rizk, Sandrine Vinault, Christine Binquet, Jean-Paul Pais de Barros, Patrick Hillon, Dominique Delmas. Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients. Oncotarget 2019; 10(22): 2161 doi: 10.18632/oncotarget.26738
|
| 16 |
John G Purdy, Micah A Luftig. Reprogramming of cellular metabolic pathways by human oncogenic viruses. Current Opinion in Virology 2019; 39: 60 doi: 10.1016/j.coviro.2019.11.002
|